Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CVX vs GSK✓SelectedUSD · GSKCVX vs GSK performance historyLatest closeAs of+0.30%11/19
Stock and ETF performance explorer

CVX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+124.8%
GSK return
+39.6%
Excess return
+85.2%
Maximum drawdown
-24.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-1.6%+1.9%+0.4%
7D-3.8%-4.7%+1.0%-3.3%
30D-7.8%-4.7%-3.1%-7.4%
3M+1.2%-8.8%+9.9%+2.0%
6M+6.5%-4.6%+11.1%+6.7%
YTD+40.4%+1.0%+39.4%+38.9%
1Y+41.1%+6.9%+34.2%+38.3%
3Y+61.7%+52.5%+9.2%+46.6%
5Y+124.8%+40.3%+84.5%+99.2%
All+124.8%+39.6%+85.2%+99.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling